Cerebellar tonsillar hemorrhages in primary central nervous system vasculitis: a potential radiologic marker
Abstract
BackgroundPrimary central nervous system vasculitis (PCNSV) is a rare inflammatory vasculopathy with diverse clinical and radiological manifestations that often delay diagnosis. Although abnormalities on magnetic resonance imaging (MRI), including susceptibility-weighted imaging (SWI), fluid-attenuated inversion recovery (FLAIR), and contrast-enhanced imaging, are increasingly recognized, a characteristic imaging pattern that may facilitate diagnosis has not yet been described. We aimed to evaluate cerebellar tonsillar hemorrhages (CTH) as a potential imaging marker of PCNSV.MethodsWe conducted a retrospective observational study at a tertiary neuroscience referral center in India. The discovery cohort included 51 patients with biopsy-proven PCNSV and 44 hypertensive microangiopathy controls who underwent MRI between 2018 and 2024. The imaging findings were independently reviewed for CTH and associated enhancement patterns. The reproducibility of this imaging pattern was subsequently assessed in an independent replication cohort of 55 patients with digital subtraction angiography (DSA)-proven PCNSV, evaluated between 2018 and 2026.ResultsCTH were identified in 35/51 (68.6%) biopsy-proven PCNSV patients compared with 9/44 (20.4%) hypertensive controls (p<0.001). In the biopsy-proven discovery cohort, CTH demonstrated a sensitivity of 68.6% (95% confidence interval [CI], 54.1–80.9%) and specificity of 79.5% (95% CI, 64.7–90.2%) for distinguishing PCNSV from hypertensive microangiopathy and remained associated with PCNSV after adjustment for age and sex (adjusted odds ratio [OR] 12.52, 95% CI 3.46–56.94). This association persisted in exploratory age-restricted sensitivity analyses. Associated punctate or linear contrast enhancement was present in 33/35 (94.3%) CTH-positive biopsy-proven patients and was not observed in hypertensive controls with available contrast-enhanced MRI (0/4). In the independent DSA-proven replication cohort, CTH were observed in 41/55 (74.5%) patients, of whom 23/39 (58.9%) demonstrated associated cerebellar tonsillar enhancement on contrast-enhanced MRI. Interobserver agreement for CTH detection was high in the combined discovery cohort (Cohen’s κ = 0.94) and the DSA-proven replication cohort (κ = 0.91). CTH frequently occurred in the absence of clinical ataxia or diffuse brainstem involvement.ConclusionCTH represent a frequent and reproducible imaging finding in both biopsy-proven and DSA-proven PCNSV. The presence of CTH, particularly when accompanied by punctate or linear enhancement, may improve the radiological suspicion of PCNSV and help distinguish inflammatory microangiopathy from hypertensive small-vessel disease.
Related
- Single-Cell and Spatial Analysis Reveals Retention of FCRL4⁺ Memory B Cells in Pediatric Tonsillar Hypertrophy
- TCR clonotyping of paired blood and tonsillar T-follicular cells reveals the mixed origin of CD38high Tfrs
- Clinical and radiologic predictors of one-year surgical outcomes in Crohn’s disease–related intra-abdominal abscesses
- Patients with Crohn’s disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone
- Little whispers in time: Review of the cerebellar unipolar brush cell, with insights for schizophrenia
BibTeX
@article{mohapatra2026cerebellar,
title = {{Cerebellar tonsillar hemorrhages in primary central nervous system vasculitis: a potential radiologic marker}},
author = {Prachi Mohapatra and Ayush Agarwal and Venugopalan Y. Vishnu and Divyani Garg and M.V. Padma Srivastava and Divya M. Radhakrishnan and Awadh Kishor Pandit and Manjari Agarwal and Rohit Bhatia and Roopa Rajan and Anu Gupta and Mamta Bhusan Singh and Mehar Chand Sharma and Vaishali Suri and Sanaullah Mudassir and Achal Kumar Srivastava and Leve Joseph Devarajan Sebastian and Shailesh B. Gaikwad and Ajay Garg},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1961925},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1961925},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Cerebellar tonsillar hemorrhages in primary central nervous system vasculitis: a potential radiologic marker
AU - Prachi Mohapatra
AU - Ayush Agarwal
AU - Venugopalan Y. Vishnu
AU - Divyani Garg
AU - M.V. Padma Srivastava
AU - Divya M. Radhakrishnan
AU - Awadh Kishor Pandit
AU - Manjari Agarwal
AU - Rohit Bhatia
AU - Roopa Rajan
AU - Anu Gupta
AU - Mamta Bhusan Singh
AU - Mehar Chand Sharma
AU - Vaishali Suri
AU - Sanaullah Mudassir
AU - Achal Kumar Srivastava
AU - Leve Joseph Devarajan Sebastian
AU - Shailesh B. Gaikwad
AU - Ajay Garg
PY - 2026
DA - 2026/11/03
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1961925
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1961925
AB - BackgroundPrimary central nervous system vasculitis (PCNSV) is a rare inflammatory vasculopathy with diverse clinical and radiological manifestations that often delay diagnosis. Although abnormalities on magnetic resonance imaging (MRI), including susceptibility-weighted imaging (SWI), fluid-attenuated inversion recovery (FLAIR), and contrast-enhanced imaging, are increasingly recognized, a characteristic imaging pattern that may facilitate diagnosis has not yet been described. We aimed to evaluate cerebellar tonsillar hemorrhages (CTH) as a potential imaging marker of PCNSV.MethodsWe conducted a retrospective observational study at a tertiary neuroscience referral center in India. The discovery cohort included 51 patients with biopsy-proven PCNSV and 44 hypertensive microangiopathy controls who underwent MRI between 2018 and 2024. The imaging findings were independently reviewed for CTH and associated enhancement patterns. The reproducibility of this imaging pattern was subsequently assessed in an independent replication cohort of 55 patients with digital subtraction angiography (DSA)-proven PCNSV, evaluated between 2018 and 2026.ResultsCTH were identified in 35/51 (68.6%) biopsy-proven PCNSV patients compared with 9/44 (20.4%) hypertensive controls (p<0.001). In the biopsy-proven discovery cohort, CTH demonstrated a sensitivity of 68.6% (95% confidence interval [CI], 54.1–80.9%) and specificity of 79.5% (95% CI, 64.7–90.2%) for distinguishing PCNSV from hypertensive microangiopathy and remained associated with PCNSV after adjustment for age and sex (adjusted odds ratio [OR] 12.52, 95% CI 3.46–56.94). This association persisted in exploratory age-restricted sensitivity analyses. Associated punctate or linear contrast enhancement was present in 33/35 (94.3%) CTH-positive biopsy-proven patients and was not observed in hypertensive controls with available contrast-enhanced MRI (0/4). In the independent DSA-proven replication cohort, CTH were observed in 41/55 (74.5%) patients, of whom 23/39 (58.9%) demonstrated associated cerebellar tonsillar enhancement on contrast-enhanced MRI. Interobserver agreement for CTH detection was high in the combined discovery cohort (Cohen’s κ = 0.94) and the DSA-proven replication cohort (κ = 0.91). CTH frequently occurred in the absence of clinical ataxia or diffuse brainstem involvement.ConclusionCTH represent a frequent and reproducible imaging finding in both biopsy-proven and DSA-proven PCNSV. The presence of CTH, particularly when accompanied by punctate or linear enhancement, may improve the radiological suspicion of PCNSV and help distinguish inflammatory microangiopathy from hypertensive small-vessel disease.
SN - 1664-3224
ER -